# YourHealthRx reviews (2026): GLP-1 telehealth sellers | This GLP One flat price regardless of dose, an oral option, and coverage in every jurisdiction. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/yourhealthrx Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Flat, wide coverage # YourHealthRx review One flat price regardless of dose, an oral option, and coverage in every jurisdiction. ## The verdict YourHealthRx publishes $140 a month for a weekly semaglutide injection with B12, flat regardless of dose. The rate needs a code and is locked while a patient stays enrolled. Tirzepatide is $190. Coverage is 51 jurisdictions. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 51 From From $140/mo Prescription Required Compounded Yes — not FDA-approved Availability 51 jurisdictions YourHealthRx sells semaglutide and tirzepatide as weekly injections with B12, and each as an oral dissolving tablet. All carry a flat price. 1. ## Who writes the prescription, and what do they see? A prescription precedes shipping. The pages state prices and plans. No clinician is described. Flat regardless of dose is the useful claim. A rate locked for as long as a patient stays enrolled removes a second decision. 2. ## What happens when the dose goes up? The price is stated flat regardless of dose, which answers the question directly. Nothing describes clinical support at a step. 3. ## What the price includes Six months at $140 is $840, and tirzepatide at $190 is $1,140. Both rates need a code at checkout. The semaglutide dissolving tablet is a separate product at $170 a month. 4. ## What it claims, and what it cites Both lines are compounded with B12. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named. ## Where it holds up, and where it does not - Strength: Flat regardless of dose - Strength: Coverage in 51 jurisdictions - Strength: An oral option priced separately - Strength: Rate locked while enrolled - Limitation: Both rates need a code - Limitation: No milligram dose published - Limitation: No compounding pharmacy is named ## What the evidence says about this kind of treatment The assessment above is about YourHealthRx. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader in any jurisdiction wanting a flat rate with little to decide. Wrong for A reader who needs a milligram stated beside the flat price. ## The evidence behind what YourHealthRx prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How YourHealthRx compares | Seller | Who it suits | Go | | --- | --- | --- | | WeightRx | Readers wanting tirzepatide who will confirm the figure before ordering | | | Woodwork | Readers ready to commit forty-eight weeks who read asterisks | | | YourEra | Readers committing six months who have read which figure belongs to which plan | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [MDLive](https://thisglp.com/reviews/mdlive) [MD Total Wellness](https://thisglp.com/reviews/mdtw) [Medical Health Institute](https://thisglp.com/reviews/medical-health-institute) [Medivive](https://thisglp.com/reviews/medivive) [MEDVidi](https://thisglp.com/reviews/medvidi) [Meli Health](https://thisglp.com/reviews/meli-health) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Does the price rise with the dose? No. It is stated flat regardless of dose. What does the rate lock mean? The $140 rate is stated as locked while you stay enrolled, billed monthly, with a code. What does the oral cost? $170 a month for the semaglutide dissolving tablet. Is YourHealthRx legit? YourHealthRx is a GLP-1 telehealth sellers service. Its stated availability: 51 jurisdictions. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is YourHealthRx expensive compared with other GLP-1 telehealth sellers? YourHealthRx publishes a starting figure of $140/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts YourHealthRx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).